Structure | Chemical Name | CAS | MF |
|
4-ESTREN-17-ALPHA-ETHYNYL-3-BETA, 17-BETA-DIOL 3-ACETATE
|
|
C22H30O3
|
|
4-ESTREN-17BETA-OL
|
|
C18H28O
|
|
5(10)-ESTREN-3-ALPHA, 17-BETA-DIOL
|
|
C18H28O2
|
|
4-Estren-3one-17beta-ol glucosiduronate
|
|
C24H34O8
|
|
4-ESTREN-3A,17B-DIOL-2,2,4,6,6,10-D6 - CONTROLLED
|
|
C18H22D6O2
|
|
4-ESTREN-3ALPHA,17BETA-DIOL-2,2,4,6,6,10-D6
|
|
C18H22D6O2
|
|
Estriol 3-Succinate
|
47575-61-1
|
C22H28O6
|
|
Estriol-d1
|
55727-98-5
|
C18H23DO3
|
|
Estriol VETRANAL
|
|
|
|
Estriol AChE Tracer
|
|
|
|
Estriol EIA Standard
|
|
|
|
Estriol EIA Antiserum
|
|
|
|
Estriol EIA Kit
|
|
|
|
(13E,15S)-9α,11β,15-Trihydroxy-6-oxo(5,8,9,11,12,14,15-3H7)prosta-13-ene-1-oic acid
|
|
|
|
(13E,15S)-9α,11α,15-Trihydroxy-6-oxo-2,3-dinorprosta-13,17-dienoic acid
|
|
|
|
Estriol-16,17-distearate
|
|
C54H92O5
|
|
(9α,11α,13E,15S)-9,11,15-Tris(trimethylsilyloxy)prost-13-en-1-oic acid methyl ester
|
52058-15-8
|
C30H62O5Si3
|
|
(13E,15S)-9α,11α,15-Trihydroxy-2,3-dinorprost-13-en-1-oic acid
|
|
|
|
Estriol-16-stearate
|
|
C36H58O4
|
|
(9β,11α,13E,15S)-9,11,15-Tris[(trimethylsilyl)oxy]prost-13-en-1-oic acid trimethylsilyl ester
|
55556-77-9
|
C32H68O5Si4
|
|
(9α,11α,13E,15S)-9,11,15-Tris[(trimethylsilyl)oxy]prost-13-en-1-oic acid trimethylsilyl ester
|
50669-94-8
|
C32H68O5Si4
|
|
Estriol-17-stearate
|
|
C36H58O4
|
|
ESTRIOL,RABBITANTI-
|
|
|
|
ESTRIOL 3-BENZOATE
|
2137-85-1
|
C25H28O4
|
|
estriol succinate
|
514-68-1
|
C26H32O9
|
|
ESTRIOL 3-BENZYL ETHER
|
18650-87-8
|
C25H30O3
|
|
ESTRIOL IMPURITY A
|
|
C18H24O3
|
|
ESTRIOL-6-OXIME ALK PHOS
|
|
|
|
ESTRIOL TRIACETATE
|
2284-32-4
|
C24H30O6
|
|
ESTRIOL-6 HRP
|
|
|
|
(3E)(2S)-1,1,1-TRIFLUORO-3-METHYL-4-PHENYLBUT-3-EN-2-YLAMINE
|
|
C11H12F3N
|
|
ESTRIOL TRIPROPIONATE
|
|
C27H36O6
|
|
Estriol 16,17-diacetate
|
805-26-5
|
C22H28O5
|
|
Estriol Tri-(2,2,2-trichloroethyl)sulfate
|
|
C24H27Cl9O12S3
|
|
ESTRIOL, [2,4-3H]- 20-40 CI(0.74-1.48 TBQ)/MMOL, MORPURE HPLC PURIFIED, DELIVERED >= 97% PURE WITH HPLC RADIOCHROMATOGRAM
|
|
|
|
ESTRIOL 3-HEMISUCCINATE
|
|
C22H28O6
|
|
ESTRIOL 16 Α-(Β-D-GLUCURONIDE)
|
|
C24H32O9
|
|
ESTRIOL TRISULFATE TRISODIUM SALT
|
100940-55-4
|
C18H21Na3O12S3
|
|
ESTRIOL, [2,4-3H]-
|
|
C18H22O3T2
|
|
ESTRIOL BSA
|
|
|
|
Estriol
|
50-27-1
|
C18H24O3
|
|
ESTRIOL 16-ACETATE
|
|
C20H26O4
|
|
EstriolSuppositories
|
|
|
|
ESTRIOL TRIACETATE MM(CRM STANDARD)
|
|
C24H30O6
|
|
ESTRIOL 3-BENZYL ETHER MM(CRM STANDARD)
|
|
C25H30O3
|
|
ESTRIOL (E3) 125I ASSAY ASSAY CHARACTERISTICS
|
|
|
|
ESTRIOL (E3) 3H ASSAY ASSAY CHARACTERISTICS
|
|
|
|
Estriol USP (Micronized)
|
|
C18H24O3
|
|
ESTRIOL,CLONECOCKTAIL,MABANTI-
|
|
|
|
ESTRIOL,SHEEPANTI-
|
|
|
|
Estriol ELISA
|
|
|
|
estriol receptor
|
|
|
|
estriol 3-glucuronide
|
2479-91-6
|
C24H32O9
|
|
estriol-16alpha-glucuronyl-6-aminobutyl-ethyl-isoluminol
|
76648-58-3
|
C38H50N4O10
|
|
estriol 3,17-dipropionate
|
104202-88-2
|
|
|
estriol 3,17-dihexanoate
|
104202-96-2
|
C30H44O5
|
|
estriol 3-sulfate
|
481-95-8
|
C18H24O6S
|
|
estriol 17-sulfate
|
42028-21-7
|
C18H24O6S
|
|
estriol glucuronide
|
28808-07-3
|
|
|
estriol 3-sulfate 16-glucuronide
|
4661-65-8
|
C24H32O12S
|
|
ESTRIOL,RABBITANTI-:RIA
|
|
|
|
ESTRIOL-6-BSA,RABBITANTI-
|
|
|
|
ESTRIOL-6-CMO-BSA,GOATANTI-:RIA
|
|
|
|
ESTRIOL,CLONE:3E01(9B4),RATMABANTI-:RIA
|
|
|
|
Estrone 3-Valerate
|
128788-26-1
|
C23H30O3
|
|
Estrone 3-Sulfate-d5 Sodium Salt
|
2734919-86-7
|
C18H21NaO5S
|
|
Estrone-d4 β-D-Glucuronide SodiuM Salt
|
|
C24H25D4NaO8
|
|
Estrofol film film - Wavenumber standard for infrared range
|
|
|
|
Estrone VETRANAL
|
|
|
|
estrone beta-glucosidase
|
|
|
|
ESTROGEN RECEPTOR-BETA, HUMAN
|
|
|
|
Estrogens, Non-Steroidal
|
|
|
|
ESTRONE, [6,7-3H(N)]
|
|
C18H18O2T4
|
|
Estrogens, Synthetic
|
|
|
|
estrophilin platinum complex
|
|
|
|
estrogen 2-hydroxylase
|
|
|
|
Estrogen Antagonists
|
|
|
|
ESTROGENRECEPTOR(ER),C-TERMINAL,E-FDOMAIN,AA495-595,CLONE:B405(AER311),MABANTI-BOVINE
|
|
|
|
ESTROGENRECEPTOR(ER),CLONE:1D5,MABANTI-HUMAN,BIOTIN:FLOW
|
|
|
|
ESTROGENREPLACEMENTTHERAPY
|
|
|
|
estrogen-induced protein
|
|
|
|
estrogen receptor-related protein 2
|
|
|
|
ESTRONE-16,16-D2 98%
|
|
|
|
ESTRONE-2,4-D2 97.1%
|
|
C26H26Cl2O4
|
|
ESTROGENRECEPTOR(ER),CLONE:ER1D5,MABANTI-HUMAN,FROZEN/PARAFFIN(W/NBREAG.)
|
|
|
|
Estrogen Receptor-a, Human, Recombinant
|
|
|
|
ESTROGENICAGENTS
|
|
|
|
estrogen-inducible membrane glycoprotein
|
|
|
|
ESTROGEN RECEPTOR-ALPHA, HUMAN
|
|
|
|
ESTROGENRECEPTOR(ER),CLONE:6F11,MABANTI-HUMAN
|
|
|
|
ESTROGENREPLACEMENT
|
|
|
|
ESTROGENSULFOTRANSFERASE,~31KD,MABANTI-RAT,PARAFFIN,IH
|
|
|
|
ESTRONE BENZOATE
|
|
C25H26O3
|
|
ESTRONE (3,4-13C2)
|
|
C18H22O2
|
|
Estrogens, Catechol
|
|
|
|
ESTROGENRECEPTOR(ER),NUCLEAR,67KD,CLONE:B30.1,MABANTI-HUMAN
|
|
|
|
estrophilin
|
|
|
|
ESTRONE-2,4,16,16-D4
|
53866-34-5
|
C18H18D4O2
|
|
Estrone-d4
|
|
C18H18D4O2
|
|
Estrone-d4 3-Sulfate Sodium Salt
|
|
C18H18D4NaO6S
|